Advertisement
Nexera Technologies Ltd

Nexera Technologies Ltd (NEXR) Stock Overview

Explore Nexera Technologies Ltd’s financial performance, market position, analyst ratings, and future outlook.

NEXRNASDAQ
HealthcareBiotechnology
$1.10
$0.54(95.56%)
U.S. Market opens in 2h 24m
Advertisement

Nexera Technologies Ltd (NEXR)

Meyka AI Score

Z

Key Financials

Market Cap711.8K
P/E Ratio-0.01
EPS (TTM)$-81.07
ROE-0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.55
3 Months$0.00
1 Year Target$0.00

NEXR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nexera Technologies Ltd (NEXR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.80, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 711.8K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
93.76%
5-Day Change
60.28%
1-Month Change
-8.41%
3-Month Change
-62.29%
6-Month Change
-72.34%
Year-to-Date (YTD) Change
-72.34%
1-Year Change
-72.34%
3-Year Change
-72.34%
5-Year Change
-72.34%
All-Time (Max) Change
-72.34%

Contact Information

972 3 771 3520
7 Mezada Street, Bnei Brak, NaN, 5126112

Company Facts

110 Employees
IPO DateApr 2, 2026
CountryIL
Actively Trading

Frequently Asked Questions